Drug Type Synthetic peptide |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypogonadism | Preclinical | US | 12 Oct 2022 | |
Diabetes Mellitus, Type 2 | Discovery | US | 12 Oct 2022 | |
HIV Infections | Discovery | US | 12 Oct 2022 | |
Klinefelter Syndrome | Discovery | US | 12 Oct 2022 | |
Neoplasms | Discovery | US | 12 Oct 2022 | |
Nonalcoholic Steatohepatitis | Discovery | US | 12 Oct 2022 | |
Obesity | Discovery | US | 12 Oct 2022 | |
Prediabetic State | Discovery | US | 12 Oct 2022 |